Projects per year
Personal profile
Education
- 1997 PhD, Pharmaceutical Science, Department of Pharmaceutical Science, College of Pharmacy, University of Kentucky
Experience
- 1998.01~2001.02 Postdoctoral Research/Harvard Medical School/Harvard University
- 2001.02~2002.02 Assistant Professor/Insititue of Biomedical Sciences, National Sun Yat-sen University
- 2002.02~2003.07 Associate Professor/Insititue of Biomedical Sciences, National Sun Yat-sen University
- 2003.08~2007.07 Associate Researcher/Kaohsiung Veterans General Hospital
- 2007.08~2010.07 Associate Professor/Institute of Clinical Medicine, NCKU
- 2009.08~2013.07 Professor/ Institute of Clinical Medicine, NCKU
- 2013.08~Present Distinguished Professor/ Institute of Clinical Medicine, NCKU
Research Interests
- Signal Transduction
- Tumor Biology
- Neurodegeneration
Expertise related to UN Sustainable Development Goals
In 2015, UN member states agreed to 17 global Sustainable Development Goals (SDGs) to end poverty, protect the planet and ensure prosperity for all. This person’s work contributes towards the following SDG(s):
Fingerprint
Dive into the research topics where Pei-Jung Lu is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Network
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
Projects
- 18 Finished
-
Carboxyl-terminal modulator protein facilitates tumor metastasis in triple-negative breast cancer
Lin, C. H., Lin, W. D., Huang, Y. C., Chen, Y. C., Loh, Z. J., Ger, L. P., Lin, F. C., Li, H. Y., Cheng, H. C., Lee, K. H., Hsiao, M. & Lu, P. J., 2023 Mar, In: Cancer Gene Therapy. 30, 3, p. 404-413 10 p.Research output: Contribution to journal › Article › peer-review
Open Access -
The activation of EP300 by F11R leads to EMT and acts as a prognostic factor in triple-negative breast cancers
Li, C. H., Fang, C. Y., Chan, M. H., Lu, P. J., Ger, L. P., Chu, J. S., Chang, Y. C., Chen, C. L. & Hsiao, M., 2023 May, In: Journal of Pathology: Clinical Research. 9, 3, p. 165-181 17 p.Research output: Contribution to journal › Article › peer-review
Open Access -
Concurrent Chemoradiotherapy-Driven Cell Plasticity by miR-200 Family Implicates the Therapeutic Response of Esophageal Squamous Cell Carcinoma
Lee, Y. C., Lin, C. H., Chang, W. L., Lin, W. D., Pan, J. K., Wang, W. J., Su, B. C., Chung, H. H., Tsai, C. H., Lin, F. C., Wang, W. C. & Lu, P. J., 2022 Apr 1, In: International journal of molecular sciences. 23, 8, 4367.Research output: Contribution to journal › Article › peer-review
Open Access2 Citations (Scopus) -
MiR-211 determines brain metastasis specificity through SOX11/NGN2 axis in triple-negative breast cancer
Pan, J. K., Lin, C. H., Kuo, Y. L., Ger, L. P., Cheng, H. C., Yao, Y. C., Hsiao, M. & Lu, P. J., 2021 Mar 4, In: Oncogene. 40, 9, p. 1737-1751 15 p.Research output: Contribution to journal › Article › peer-review
Open Access13 Citations (Scopus) -
Stationed or relocating: The seesawing emt/met determinants from embryonic development to cancer metastasis
Li, C. H., Hsu, T. I., Chang, Y. C., Chan, M. H., Lu, P. J. & Hsiao, M., 2021 Sept, In: Biomedicines. 9, 9, 1265.Research output: Contribution to journal › Article › peer-review
Open Access8 Citations (Scopus)